Bringing precision medicine to breast cancer care in Queensland.
Q-IMPROvE implementation of precision oncology in breast cancer
Cancer is a heterogeneous disease, differing greatly between patients. This makes it difficult for doctors to predict whether or not standard treatments, such as chemotherapy, will provide any benefit to a particular patient.
This project will use whole genome sequencing to identify the unique profile of an individual’s tumour.
That data will help clinicians predict which patients are more likely to respond well to specific cancer treatments, tailoring each patient’s treatment plan to target the genetic abnormalities of their cancer.
This is a clinical innovation project, which explores new applications of medical genomics in clinical practice.